<DOC>
	<DOCNO>NCT00326976</DOCNO>
	<brief_summary>The purpose study evaluate whether FX06 capable limit infarct size follow balloon catheterization acute myocardial infarction .</brief_summary>
	<brief_title>Efficacy FX06 Prevention Myocardial Reperfusion Injury</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Myocardial Reperfusion Injury</mesh_term>
	<criteria>Patients give informed consent Patients primary percutaneous coronary intervention ( PCI ) acute STelevation myocardial infarction ( STEMI ) Men woman child bear potential Onset symptom balloon time &lt; 6 hour STelevation least 2 mm least 3 lead 12lead electrocardiogram ( ECG ) Primary PCI indicate per standard care First myocardial infarction ( MI ) Single index lesion complete occlusion [ thrombolysis myocardial infarction ( TIMI ) flow 0/I ] one target vessel . History MI ( patient history , ECG ) Chest pain angina symptoms 24 hour first recognize symptom acute myocardial infarction ( AMI ) Need coronary artery bypass graft ( CABG ) Administration thrombolytic agent since onset AMI symptom Serious procedural complication ( e.g. , procedural unintended occlusion coronary artery branch , cardiac tamponade , emergency bypass operation , LM dissection , etc . ) Presence cardiogenic shock : hemodynamically unstable and/or need positive inotropic agent Contraindication cardiovascular magnetic resonance ( CMR ) : claustrophobia , pacemaker , defibrillator electronic device , metallic cerebral clip ; frequent extrasystole ( &gt; 12/Min ) atrial fibrillation ( AF ) . Known renal dysfunction define serum creatinine &gt; 250 Âµmol/l Previous CABG History congestive heart failure ( CHF ) Body mass index ( BMI ) &gt; 35 Patients communicate reliably investigator Patients unlikely cooperate requirement study Patients unwilling and/or unable give inform consent Patients increase risk death preexist concurrent illness Patients participate another clinical study Patients use investigational drug within 1 month first dose Patients participate already study Patients employee investigational site ; relative spouse investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
	<keyword>Myocardial Revascularization</keyword>
</DOC>